本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Dianthus Therapeutics Inc.

36.78
+1.213.41%
成交量:175.62萬
成交額:6,255.65萬
市值:11.84億
市盈率:-11.32
高:36.99
開:33.80
低:33.50
收:35.57
52周最高:36.99
52周最低:13.37
股本:3,218.83萬
流通股本:1,345.91萬
量比:1.24
換手率:13.05%
股息:- -
股息率:- -
每股收益(TTM):-3.2490
每股收益(LYR):-2.5506
淨資產收益率:-34.71%
總資產收益率:-23.37%
市淨率:3.91
市盈率(LYR):-14.42

資料載入中...

2024/10/07

SEC問詢函

Form CORRESP - Correspondence
2024/09/16

重要事件披露

Form 8-K - Current report
2024/09/12

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/08/08

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/08/08

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/08

重要事件披露

Form 8-K - Current report
2024/06/06

重要事件披露

Form 8-K - Current report
2024/05/28

重要事件披露

Form 8-K - Current report
2024/05/09

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/09

重要事件披露

Form 8-K - Current report
2024/04/01

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/03/26

SEC問詢函

Form CORRESP - Correspondence
2024/03/21

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/21

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/03/21

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/21

重要事件披露

Form 8-K - Current report
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/09

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]